ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #20,204Hybrid

Egyptian Pharmaceutical Journal

Identifier (ISSN):1687-4315(Print)/2090-9853(Online)
•
Publisher:Wolters Kluwer Health
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.9↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Egyptian Pharmaceutical Journal

WoS Q4
0112020230.720240.620250.92026
Annual Impact Factor Metric
Current (2026):0.9
Scopus SJR & RankScopus Q3
0.23
#20,204

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
13

13 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate14.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
31articles/year
22.34% Gold OA•93.55% Original Research

Aims & Scope

Egyptian Pharmaceutical Journal (ISSN: 1687-4315) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Wolters Kluwer Health. The periodical holds a Journal Impact Factor (JIF) of 0.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.230 (Q3), an H-index of 13.

Topics Covered (Recognized by AI)
Biology95.5%Chemistry87.6%Biochemistry72.2%Medicine71.4%Organic chemistry67.7%Genetics57.9%Physics40.2%Botany39.1%Internal medicine37.6%Geology33.1%Paleontology32%Pharmacology32%Food science30.8%Chromatography29.3%Microbiology26.3%Nuclear magnetic resonance25.2%Traditional medicine25.2%Endocrinology23.7%Bacteria23.7%Enzyme21.4%Ecology20.7%Antioxidant20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank321/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank333/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.9
Articles / Year20
Total Citations0
2025
IF0.6
Articles / Year61
Total Citations18
2024
IF0.7
Articles / Year78
Total Citations100
2023
IF0
Articles / Year76
Total Citations163
2022
IF—
Articles / Year56
Total Citations159

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #20,204Scopus Q3SCImago Profile
Scopus Coverage:2019-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.23

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.96

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,450 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations186
3-Year Documents194
Citable Documents194

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate59.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Applied Microbiology and BiotechnologyQ3
Biochemistry, Genetics and Molecular Biology (miscellaneous)Q3
Pharmaceutical ScienceQ3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q3
ToxicologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Egyptian Pharmaceutical Journal (ISSN: 1687-4315) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Wolters Kluwer Health. The periodical holds a Journal Impact Factor (JIF) of 0.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.230 (Q3), an H-index of 13.

The journal enforces rigorous peer evaluation with an annual output of approximately 31 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,450 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wolters Kluwer Health
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b1f911bc-11e4-4031-833f-558ee390d3ee
Database Updated: 2026-09-29